ARTICLE | Company News
Alere Inc, Qiagen deal
April 13, 2015 7:00 AM UTC
Qiagen purchased circulating tumor cell (CTC) detection technology and two diagnostics -- AdnaTest BreastCancer and AdnaTest Prostate Cancer -- from Alere’s AdnaGen GmbH subsidiary. AdnaTest BreastCa...